STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive: Upregulation of cryptotanshinone on the expression of p-STAT5 supported protection against ischemic stroke (Zhu et al., 2021), whereas the inhibitory effect of cryptotanshinone effectively antagonized chronic myelocytic leukemia (CML) (Dong et al., 2018).